Benitec Biopharma Inc. (BNTC)
10.47
0.09 (0.87%)
At close: Jan 15, 2025, 10:10 AM
Benitec Biopharma Inc. Revenue Breakdown
| Quarter | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
|---|---|---|---|
| License Revenue | 1K | 1K | 55.00K |
| License Revenue Growth | 0.00% | -98.18% | n/a |
| Royalty Revenue | 0 | 0 | 0 |
| Royalty Revenue Growth | n/a | n/a | n/a |
| Service Revenue | 0 | 0 | 0 |
| Service Revenue Growth | n/a | n/a | n/a |
Revenue by Geography
| Quarter | Jun 30, 2019 | Jun 30, 2018 |
|---|---|---|
| Australia Revenue | 14.63M | 378.00K |
| Australia Revenue Growth | +3769.58% | n/a |
Operating Expense Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.21M | 2.04M | 1.49M | 1.82M | 1.55M | 1.37M | 1.23M | 1.86M | 1.92M | 1.55M | 1.34M | 1.71M | 2.04M | 1.54M | 1.03M | 2.11M | 1.84M | 1.90M | 1.29M | 1.90M | 750.00K | 860.00K | 1.10M | 939.70K | 1.75M | 1.42M | 1.63M | 1.64M | 1.72M | 1.67M | 1.90M | 1.75M | 1.67M | 1.61M | 2.26M | 3.20M | 1.89M | 1.89M | 1.15M |
| Selling, General, and Administrative Revenue Growth | +8.35% | +36.83% | -18.42% | +17.60% | +13.13% | +11.64% | -34.08% | -2.97% | +23.63% | +16.16% | -22.00% | -16.06% | +32.94% | +49.27% | -51.26% | +14.92% | -3.21% | +47.47% | -32.08% | +152.67% | -12.79% | -22.03% | +17.38% | -46.45% | +23.61% | -13.00% | -0.49% | -4.61% | +3.02% | -12.33% | +8.99% | +4.45% | +3.67% | -28.53% | -29.46% | +68.88% | +0.15% | +64.86% | n/a |
| Research and Development Revenue | 3.58M | 3.51M | 2.57M | 5.10M | 4.43M | 3.19M | 3.17M | 3.76M | 2.66M | 3.18M | 2.17M | 3.15M | 2.78M | 2.32M | 2.76M | 1.17M | 774.00K | 906.00K | 805.00K | 599.00K | 423.00K | 1.26M | 1.16M | 1.56M | 595.91K | 1.33M | 1.17M | 1.46M | 1.10M | 1.28M | 1.16M | 960.37K | 1.92M | 1.42M | 2.56M | 1.69M | 4.25M | 1.58M | 1.39M |
| Research and Development Revenue Growth | +2.08% | +36.87% | -49.71% | +15.20% | +39.01% | +0.60% | -15.79% | +41.39% | -16.25% | +46.29% | -30.99% | +13.17% | +19.83% | -15.88% | +136.13% | +50.90% | -14.57% | +12.55% | +34.39% | +41.61% | -66.51% | +8.97% | -25.89% | +162.44% | -55.13% | +13.92% | -20.42% | +32.78% | -13.58% | +9.57% | +21.31% | -49.97% | +34.85% | -44.48% | +51.98% | -60.28% | +168.81% | +13.79% | n/a |